References
- Appelbaum L, Ben-David E, Faroja M, Nissenbaum Y, Sosna J, Goldberg SN. Irreversible electroporation ablation: creation of large-volume ablation zones in in vivo porcine liver with four-electrode arrays. Radiology 2014; 270: 416-24. 10.1148/radiol.1313034924126371
- Charpentier KP, Wolf F, Noble L, Winn B, Resnick M, Dupuy DE. Irreversible electroporation of the liver and liver hilum in swine. HPB (Oxford) 2011; 13: 168-73. 10.1111/j.1477-2574.2010.00261.x21309933
- Davalos RV, Mir IL, Rubinsky B. Tissue ablation with irreversible electroporation. Ann Biomed Eng 2005; 33: 223-31. 10.1111/j.1477-2574.2010.00261.x15771276
- Bower M, Sherwood L, Li Y, Martin R. Irreversible electroporation of the pancreas: definitive local therapy without systemic effects. J Surg Oncol 2011; 104: 22-8. 10.1002/jso.2189921360714
- Daniels C, Rubinsky B. Electrical field and temperature model of nonthermal irreversible electroporation in heterogeneous tissues. J Biomech Eng 2009; 131: 071006. 10.1115/1.315680819640131
- Al-Sakere B, Bernat C, Andre F, Connault E, Opolon P, Davalos RV, et al. A study of the immunological response to tumor ablation with irreversible electroporation. Technol Cancer Res Treat 2007; 6: 301-6. 10.1177/15330346070060040617668937
- Bellard E, Markelc B, Pelofy S, Le Guerroue F, Sersa G, Teissie J, et al. Intravital microscopy at the single vessel level brings new insights of vascular modification mechanisms induced by electropermeabilization. J Control Release 2012; 163: 396-403. 10.1016/j.jconrel.2012.09.01023017380
- Dollinger M, Zeman F, Niessen C, Lang SA, Beyer LP, Muller M, et al. Bile duct injury after irreversible electroporation of hepatic malignancies: evaluation of MR imaging findings and laboratory values. J Vasc Interv Radiol 2016; 27: 96-103. 10.1016/j.jvir.2015.10.00226777402
- Kanthou C, Kranjc S, Sersa G, Tozer G, Zupanic A, Cemazar M. The endothelial cytoskeleton as a target of electroporation-based therapies. Mol Cancer Ther 2006; 5: 3145-52. 10.1158/1535-7163.MCT-06-041017172418
- Maor E, Rubinsky B. Endovascular nonthermal irreversible electroporation: a finite element analysis. J Biomech Eng 2010; 132: 031008. 10.1115/1.400103520459196
- Ben-David E, Ahmed M, Faroja M, Moussa M, Wandel A, Sosna J, et al. Irreversible electroporation: treatment effect is susceptible to local environment and tissue properties. Radiology 2013; 269: 738-47. 10.1148/radiol.1312259023847254
- Ivorra A, Villemejane J, Mir LM. Electrical modeling of the influence of medium conductivity on electroporation. Phys Chem Chem Phys 2010; 12: 10055-64. 10.1089/c004419a20585676
- Qasrawi R, Silve L, Burdio F, Abdeen Z, Ivorra A. Anatomically realistic simulations of liver ablation by irreversible electroporation. Technol Cancer Res Treat 2017. 10.1177/1533034616687477. [Epub ahead of print]28093955
- Peyman A, Kos B, Djokic M, Trotovsek B, Limbaeck-Stokin C, Sersa G, et al. Variation in dielectric properties due to pathological changes in human liver. Bioelectromagnetics 2015; 36: 603-12. 10.1002/bem.2193926508012
- Sanchez-Velazquez P, Castellvi Q, Villanueva A, Iglesias M, Quesada R, Panella C, et al. Long-term effectiveness of irreversible electroporation in a murine model of colorectal liver metastasis. Sci Rep 2017; 7: 44821. 10.1038/srep44821
- Sanchez-Velazquez P, Castellvi Q, Villanueva A, Quesada R, Panella C, Caceres M, et al. Irreversible electroporation of the liver: is there a safe limit to the ablation volume? Sci Rep 2016; 6: 23781. 10.1038/srep23781
- Castellvi Q, Sanchez-Velazquez P, Moll X, Berjano E, Andaluz A, Burdio F, et al. Modeling liver electrical conductivity during hypertonic injection. Int J Numer Meth Bio 2017. 10.1002/cnm.2904. [Epub ahead of print]
- Castellví Q, Sánchez-Velázquez P, Berjano E, Burdío F, Ivorra A. Selective electroporation of liver tumor nodules by means of hypersaline infusion: A feasibility study. In: Lacković I, Vasic D, editors. 6th European Conference of the International Federation for Medical and Biological Engineering: MBEC 2014, 7-11 September 2014, Dubrovnik, Croatia. Cham: Springer International Publishing; 2015. p. 821-4. 10.1007/978-3-319-11128-5_204
- Dezso K, Bugyik E, Papp V, Laszlo V, Dome B, Tovari J, et al. Development of arterial blood supply in experimental liver metastases. Am J Pathol 2009; 175: 835-43. 10.2353/ajpath.2009.09009519574433
- Liu Y, Matsui O. Changes of intratumoral microvessels and blood perfusion during establishment of hepatic metastases in mice. Radiology 2007; 243: 386-95. 10.1148/radiol.243206034117356176
- Morton DB, Griffiths PH. Guidelines on the recognition of pain, distress and discomfort in experimental animals and an hypothesis for assessment. Vet Rec 1985; 116: 431-6.10.1136/vr.116.16.4313923690
- Sala J, Guardia E, Marti J. Effects of concentration on structure, dielectric, and dynamic properties of aqueous NaCl solutions using a polarizable model. J Chem Phys 2010; 132: 214505. 10.1063/1.342925320528029
- Yamaguchi T, Matsuoka T, Koda S. A theoretical study on the frequency-dependent electric conductivity of electrolyte solutions. II. Effect of hydrodynamic interaction. J Chem Phys 2009; 130: 094506. 10-1063/1.308571719275408
- Laufer S, Ivorra A, Reuter VE, Rubinsky B, Solomon SB. Electrical impedance characterization of normal and cancerous human hepatic tissue. Physiol Meas 2010; 31: 995-1009. 10.1088/0967-3334/31/7/00920577035
- Ruiz-Vargas A, Arkwright JW, Ivorra A, editors. A portable bioimpedance measurement system based on Red Pitaya for monitoring and detecting abnormalities in the gastrointestinal tract. 2016 IEEE EMBS Conference on Biomedical Engineering and Sciences (IECBES); 2016 4-8 Dec. 2016. 10.1016/j.hpb.2016.03.609
- Tyagi R, Donaldson K, Loftus CM, Jallo J. Hypertonic saline: a clinical review. Neurosurg Rev 2007; 30: 277-89; discussion 89-90. 10.1007/s10143-007-0091-717574484
- Muftuler LT, Hamamura MJ, Birgul O, Nalcioglu O. In vivo MRI electrical impedance tomography (MREIT) of tumors. Technol Cancer Res Treat 2006; 5: 381-7.16866568
- Valerio M, Dickinson L, Ali A, Ramachandran N, Donaldson I, Freeman A, et al. A prospective development study investigating focal irreversible electroporation in men with localised prostate cancer: Nanoknife Electroporation Ablation Trial (NEAT). Contemp Clin Trials 2014; 39: 57-65. 10.1016/j.cct.2014.07.00625072507
- van den Bos W, de Bruin DM, Muller BG, Varkarakis IM, Karagiannis AA, Zondervan PJ, et al. The safety and efficacy of irreversible electroporation for the ablation of prostate cancer: a multicentre prospective human in vivo pilot study protocol. BMJ open 2014; 4: e006382. 10.1136/bmjopen-2014-00638225354827
- Wendler JJ, Porsch M, Nitschke S, Kollermann J, Siedentopf S, Pech M, et al. A prospective Phase 2a pilot study investigating focal percutaneous irreversible electroporation (IRE) ablation by NanoKnife in patients with localised renal cell carcinoma (RCC) with delayed interval tumour resection (IRENE trial). Contemp Clin Trials 2015; 43: 10-9. 10.1016/j.cct.2015.05.00225962890
- Sahakian AV, Al-Angari HM, Adeyanju OO. Electrode activation sequencing employing conductivity changes in irreversible electroporation tissue ablation. IEEE Trans Biomed Eng 2012; 59: 604-7. 10.1109/TBME.2011.218072222194234